An anticonvulsant
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Product Categories

Product Type

Ethotoin

Item No. 24022

Technical Information
Formal Name
3-ethyl-5-phenyl-2,4-imidazolidinedione
CAS Number
86-35-1
Synonyms
  • (±)-Ethotoin
Molecular Formula
C11H12N2O2
Formula Weight
Purity
≥95%
A solid
DMSO: Slightly SolubleMethanol: Slightly Soluble
SMILES
O=C(C(C1=CC=CC=C1)N2)N(CC)C2=O
InChi Code
InChI=1S/C11H12N2O2/c1-2-13-10(14)9(12-11(13)15)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H,12,15)
InChi Key
SZQIFWWUIBRPBZ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    Ethotoin is a hydantoin anticonvulsant.1,2 It shortens the duration of the tonic extensor aspect of seizures induced by maximal electroshock in rats when administered at doses ranging from 500-1,000 mg/kg.2 It also decreases the duration of the tonic phase of seizures at a dose of 1,000 mg/kg but does not affect the duration of the clonic phase at any dose.2 Ethotoin (20 mg/kg, i.p.) decreases serum cholesterol and triglyceride concentrations in mice to 67 and 60%, respectively, of control after 16 days of treatment.3 Formulations containing ethotoin have been used in the treatment of tonic-clonic and complex partial seizures.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Livingston, S. The use of peganone (AC 695) in the treatment of epilepsy. J. Pediatr. 49(6), 728-732 (1956).

    2. Kamei, C., Masuda, Y., Oka, M., et alEffects of antiepileptics on both behavioral and electrographic seizure patterns induced by maximal electroshock in rats. Epilepsia 19(6), 625-636 (1978).

    3. Maguire, J.H., Murthy, A.R., and Hall, I.H. Hypolipidemic activity of antiepileptic 5-phenylhydantoins in mice. Eur. J. Pharmacol. 117(1), 135-138 (1985).